While its effectiveness is still being researched, clinical therapists across the country and here at Bryan Medical say it’s mostly beneficial for treatment-resistant depression patients.

Reports of Elon Musk’s drug use have renewed attention to ketamine, a powerful anesthetic.

A ketamine derivative, esketamine under the brand name Spravato, is FDA-approved as a nasal spray to treat depression in adults, according to the National Institute on Drug Abuse.

There’s also a nasal spray called esketamine. While the drug isn’t pure ketamine, but rather a component of it, it’s similar enough that it often gets lumped under the ketamine therapy umbrella.

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one roof would be ideal.

Medicare covers some forms of ketamine, but it doesn’t cover ketamine therapy for mental health conditions. Read more.

In 2019, the FDA approved a nasal spray containing a form of ketamine called esketamine (sold under the brand name Spravato) for patients with depression who hadn’t responded to other treatments.

Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...

The esketamine label carries a boxed warning for the risks of sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and ...